How the iQue® platform helps AlivaMab Discovery Services accelerate the delivery of fully human, CMC-ready lead candidates

21 September 2021

AlivaMab Discovery Services is striving to advance healthcare with its visionary approach to drug discovery through superior antibody therapeutics. In this expert video interview, Dr. Linda Masat, head of European and strategic business development, and Dr. Jonah Rainey, VP of antibody engineering and protein science, offer insight into the current and future projects at AlivaMab Discovery Services, highlighting the integral role of the Sartorius iQue® platform in increasing the efficiency and productivity of AlivaMab's workflow.